Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-070396
Filing Date
2025-05-13
Accepted
2025-05-13 16:19:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 21517
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 194186
3 EX-99.2 ck0001669811-ex99_2.pdf EX-99.2 166277
  Complete submission text file 0000950170-25-070396.txt   520183
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Subject) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92925 | Film No.: 25940418
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address 20 UNIVERSITY ROAD, 4TH FLOOR CAMBRIDGE MA 02138
Business Address 20 UNIVERSITY ROAD, 4TH FLOOR CAMBRIDGE MA 02138 617-234-7000
General Catalyst Group Management Holdings GP, LLC (Filed by) CIK: 0001774565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A